dsm-firmenich
We bring progress to life
Be part of a relevant ecosystem focused on industrial biotechnology
dsm-ferminich is highly dedicated to contributing to a more sustainable economy and society. Already for 150 years, dsm-ferminich in Delft (previously Gist Brocades and Nederlandsche Gist en Spiritus Fabriek) has been a front runner in biotechnological innovations with global impact.
The board of dsm-ferminich has given its commitment to open its site in Delft for third parties active in biotechnology, and to share its knowledge and infrastructure to create an open innovation campus.
The dsm-ferminich Biotechnology Centre at the Biotech Campus Delft houses over 400 scientists with expertise in all areas of Biotechnology. Ranging from bioinformatics, analytics, fermentation, downstream processing and application. Collaborations and mentoring between Planet B.io and dsm-ferminich scientists is actively promoted. Moreover, dsm-ferminich can offer valuable commercial support and business opportunities.
Latest news
Planet B.io is a busy community, we are constantly developing and so are our collaborators, residents and members. To keep everyone updated we write articles and organise events. Take a look!
Meet the newest Planet B.io residents
Supporting innovation through Kansen voor West vouchers
Over the past year, Planet B.io has supported a diverse group of innovative companies through the Kansen voor West vouchers. These vouchers are designed to help entrepreneurs take the next step in developing and scaling sustainable bio-based and food innovations by providing targeted support for advisory services, process optimisation, and establishment.
One year later: Insights from Scale-up frontrunners | Stef Denayer, Pilots4U
It’s been a year since Planet B.io’s Let’s Talk Bio Scale-Up event brought together leading scale-up experts, and the journey continues. We sat down with Stef Denayer, Stakeholder Relations Manager at Pilots4U, to explore how the platform has been renewed, what it now offers innovators across Europe, and how it helps connect them with open-access pilot and demo facilities to accelerate their path from idea to market. From a rebuilt digital platform to on-site study visits and travel vouchers for pilot plant engagement, discover the latest developments in Europe’s infrastructure for scaling biobased innovation.
Fenneke Jolink